feed,title,long_url,short_url
Benzinga,GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer,https://benzinga.com/general/biotech/24/03/37791892/gsk-reveals-new-phase-3-data-for-jemperli-combo-therapy-to-support-expanded-use-approval-for-wide,https://da.gd/3H6X5W
